TNFRSF10B and cancer: The proposed mechanism of action involves the induction of caspase-8-dependent apoptosis by the pro-apoptotic tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), mediated by death receptors 4 and 5 (DR4 and DR5, respectively) on cancer cells.